CFTR and cystic fibrosis: In cystic fibrosis, the ΔF508 mutation in cystic fibrosis transmembrane regulator (CFTR) protein, which occurs in 70% of cystic fibrosis patients, has a decreased stability compared to WT, leading to a decrease in the functional protein concentration in vivo and hence net decreased function [37], [38].